« Previous
Next »
Surgery
Volume 146, Issue 5
, Pages 906-912
, November 2009
Long-term outcome of “prophylactic therapy” for familial medullary thyroid cancer
References
- . Medullary thyroid cancer: therapeutic targets and molecular markers. Curr Opin Oncol. 2007;19:18–23
- . Current approaches to medullary thyroid carcinoma, sporadic and familial. J Surg Oncol. 2006;94:737–747
- . Preoperative diagnosis of medullary thyroid carcinoma: Fine needle aspiration cytology as compared with serum calcitonin measurement. J Surg Oncol. 2005;91:56–60
- . Medullary thyroid carcinoma: including MEN 2A and MEN 2B syndromes. J Surg Oncol. 2005;89:122–129
- . Multiple endocrine neoplasia type 2: 2007 update. Horm Res. 2007;68(Suppl 5):101–104
- . Prophylactic thyroidectomy in multiple endocrine neoplasia: the impact of molecular mechanisms of RET proto-oncogene. Langenbeck Arch Surg. 2003;388:17–26
- . Mutation analysis of the RET proto-oncogene and early thyroidectomy: results of a Portuguese cancer centre. Surgery. 2007;141:90–95
- RET proto-oncogene mutations are restricted to codon 634 and 618 in Korean families with multiple endocrine neoplasia 2A. Thyroid. 2004;14:813–818
- . Tiroidectomía profiláctica en ninos y jóvenes con cáncer medular tiroideo hereditario: experiencia chilena. Rev Méd Chile. 2005;133:1029–1036
- . Prophylactic thyroidectomy in multiple endocrine neoplasia type 2A. N Engl J Med. 2005;353:1105–1113
- Long-term outcome in 46 gene carriers of hereditary medullary thyroid carcinoma after prophylactic thyroidectomy: impact of individual RET genotype. Eur J Endocrinol. 2006;155:229–236
- Prophylactic thyroidectomy in 75 children and adolescents with hereditary medullary thyroid carcinoma: German and Austrian experience. World J Surg. 1998;22:744–751
- Early malignant progression of hereditary medullary thyroid cancer. N Engl J Med. 2003;349:1517–1525
- . Advances in the management of hereditary medullary thyroid cancer. J Intern Med. 2005;257:50–59
- . Genotype-phenotype based surgical concept of hereditary medullary thyroid carcinoma. World J Surg. 2007;31:957–968
- . Determinative factors of biochemical cure after primary and reoperative surgery for sporadic medullary thyroid carcinoma. World J Surg. 1998;22:562–568
- . Thyreoidektomie und Lymphadenektomie. Chirurg. 1999;70:987–998
- Current approaches and perspectives in the therapy of medullary thyroid carcinoma. Cancer. 2001;91:1797–1808
- RET proto-oncogene: a review and update of genotype-phenotype correlations in hereditary medullary thyroid cancer and associated endocrine tumors. Thyroid. 2005;15:531–544
- . Malignant progression from C-cell hyperplasia to medullary thyroid carcinoma in 167 carriers of RET germline mutations. Surgery. 2003;134:425–431
- . Presymptomatic thyroidectomy in multiple endocrine neoplasia 2a. EJSO. 2006;32:98–102
- Early presentation of metastatic medullary carcinoma in multiple endocrine neoplasia, type IIA: implications for therapy. J Pediatr. 1996;129:459–464
- . Lymphadenektomie beim Schilddrüsen- und Nebenschilddrüsenkarzinom. Chirurg. 2007;78:182–193
- . Lymph node dissection in patients with differentiated thyroid carcinoma—who benefits?. Langenbeck Arch Surg. 1998;383:355–358
- . Curages cervicaux et cancers thyroidiens. Ann Chir. 2003;128:468–474
- Rationale for central and bilateral lymph node dissection in sporadic and hereditary medullary thyroid cancer. J Clin Endocrinol Metab. 2003;88:2070–2075
- Natural history, diagnosis, treatment and outcome of medullary thyroid cancer: 37 years experience on 157 patients. EJSO. 2007;33:493–497
- . Locoregional recurrence and death from medullary thyroid carcinoma in a contemporaneous series: 5-year results. Eur J Endocrinol. 2007;157:85–93
PII: S0039-6060(09)00324-9
doi: 10.1016/j.surg.2009.06.007
© 2009 Mosby, Inc. All rights reserved.
« Previous
Next »
Surgery
Volume 146, Issue 5
, Pages 906-912
, November 2009
